Introducing new medicines in the NHS in the UK
Monday, 23 June 2025 10:17
Introducing new medicines in the NHS in the UK - pathway Details
The pathway covers the regulatory and access route for companies
wishing to introduce new medicines to the NHS. The process
includes: companies notifying the health and care system of their
products through UK Pharmascan the advisory services that are
available to companies marketing authorisation and health
technology evaluation processes The pathway does not include
clinical trial stages...Request free
trial
|